News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,997 Results
Type
Article (39240)
Company Profile (282)
Press Release (650475)
Section
Business (203959)
Career Advice (1999)
Deals (35391)
Drug Delivery (89)
Drug Development (80889)
Employer Resources (168)
FDA (16112)
Job Trends (14815)
News (344747)
Policy (32457)
Tag
Academia (2530)
Alliances (49263)
Alzheimer's disease (1290)
Approvals (16078)
Artificial intelligence (164)
Bankruptcy (354)
Best Places to Work (11604)
Biotechnology (199)
Breast cancer (204)
Cancer (1530)
Cardiovascular disease (121)
Career advice (1665)
CAR-T (106)
Cell therapy (314)
Clinical research (64948)
Collaboration (575)
Compensation (308)
COVID-19 (2550)
C-suite (133)
Data (1472)
Diabetes (190)
Diagnostics (6201)
Earnings (85049)
Employer resources (146)
Events (110381)
Executive appointments (491)
FDA (16889)
Funding (519)
Gene therapy (215)
GLP-1 (622)
Government (4339)
Healthcare (18739)
Infectious disease (2647)
Inflammatory bowel disease (114)
Interviews (309)
IPO (16395)
Job creations (3625)
Job search strategy (1418)
Layoffs (424)
Legal (7870)
Lung cancer (226)
Manufacturing (214)
Medical device (13233)
Medtech (13238)
Mergers & acquisitions (19259)
Metabolic disorders (494)
Neuroscience (1652)
NextGen: Class of 2025 (6506)
Non-profit (4471)
Northern California (1872)
Obesity (281)
Opinion (186)
Patents (133)
People (56652)
Phase I (20214)
Phase II (28604)
Phase III (21309)
Pipeline (615)
Postmarket research (2561)
Preclinical (8555)
Radiopharmaceuticals (239)
Rare diseases (288)
Real estate (5894)
Regulatory (21791)
Research institute (2312)
Resumes & cover letters (349)
Southern California (1617)
Startups (3566)
United States (16689)
Vaccines (579)
Weight loss (194)
Date
Today (126)
Last 7 days (420)
Last 30 days (1944)
Last 365 days (34842)
2025 (1816)
2024 (35259)
2023 (40079)
2022 (51180)
2021 (55718)
2020 (54088)
2019 (46541)
2018 (35019)
2017 (32113)
2016 (31481)
2015 (37554)
2014 (31319)
2013 (26346)
2012 (28570)
2011 (29263)
2010 (27329)
Location
Africa (713)
Arizona (203)
Asia (37401)
Australia (6107)
California (4258)
Canada (1561)
China (364)
Colorado (193)
Connecticut (205)
Europe (80077)
Florida (608)
Georgia (147)
Illinois (414)
Indiana (242)
Maryland (686)
Massachusetts (3287)
Michigan (183)
Minnesota (317)
New Jersey (1190)
New York (1206)
North Carolina (798)
Northern California (1872)
Ohio (155)
Pennsylvania (1001)
South America (1093)
Southern California (1617)
Texas (621)
Utah (121)
Washington State (428)
689,997 Results for "chimerix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Chimerix to Speak Today at The White House Cancer Moonshot Forum
January 14, 2025
·
3 min read
Bio NC
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 16, 2024
Chimerix announced that on April 10, 2024, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to four new employees of non-statutory stock options to purchase up to a total of 223,000 shares of Chimerix’s common stock.
April 16, 2024
·
1 min read
Press Releases
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 6, 2024
December 9, 2024
·
1 min read
Business
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update
Chimerix reported financial results for the first quarter ended March 31, 2024 and provided an operational update.
May 1, 2024
·
9 min read
Bio NC
Chimerix to Participate in Fireside Chat at Jefferies 2024 Global Healthcare Conference
Chimerix announced that Mike Andriole, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 3:00 p.m. ET.
May 30, 2024
·
1 min read
Press Releases
Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update
November 7, 2024
·
9 min read
Press Releases
Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
December 30, 2024
·
4 min read
Business
Chimerix Appoints Marc D. Kozin to Board of Directors
Chimerix, a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, announced the appointment of Marc D. Kozin as the newest member of the Company’s Board of Directors.
March 21, 2024
·
2 min read
Press Releases
Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024
November 1, 2024
·
1 min read
Press Releases
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - October 18, 2024
October 21, 2024
·
1 min read
1 of 69,000
Next
